An official website of the United States government

NIH: National Institute of Diabetes and Digestive and Kidney Diseases
NIDDK Central Repository
Search
Filters

Study Acronym

HALT-C

1 - 10 of 10 Results
  • 1
Page
Show:
Study Search Results Table
Title
PMID
PMCID
Public Release Type
Publication Year
DOI
Study Acronym
Request ID(s)
Public Release Origin
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.21520194PMC3144992Journal201110.1002/hep.24370HALT-CContributing Study
Biomarkers of active fibrogenesis and immune cell activity are each predictors of specific liver-related outcomes in patients with chronic hepatitis CConference Presentation2024HALT-C23096Secondary Research
Comparison of approaches for incorporating new information into existing risk prediction models.27943382Journal201710.1002/sim.7190Virahep-C, HALT-C10835Secondary Research
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.26186989PMC4615534Journal201510.1016/j.jhep.2015.06.035Virahep-C, HALT-C10835Secondary Research
Fibroblast activity kills - Circulating endotrophin (PRO-C6) is prognostic for liver-related events in cirrhotic patients with chronic hepatitis CConference Presentation2024HALT-C23096Secondary Research
PR0-C3 determined active fibrogenesis is a predictor of liver-related outcomes in patients with chronic hepatitis CConference Presentation2024HALT-C23096Secondary Research
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.19052125PMC2606037Journal200810.1056/NEJMoa0707615HALT-CContributing Study
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.27375287PMC5841614Journal201610.1093/ije/dyw118ATN, MTOPS, HEMO, FAVORIT, DPP, SISTEr, HALT-C6371, 6372, 6830, 8068, 8148, 8168, 8169, 8170Secondary Research
Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection.26541123Journal201610.1017/S0007114515004158HALT-C1608Secondary Research
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C.25135867PMC4272642Journal201510.1016/j.jhep.2014.08.013HALT-C7988Secondary Research
  • 1
Page